Skip to main content

Applied Biosystems to Market Covaris Sample-Prep Instrument with SOLiD System

NEW YORK (GenomeWeb News) – Applied Biosystems will sell Covaris’ sample preparation systems to support its SOLiD System genetic analyzers, Covaris said today.
 
Under the agreement, ABI will market and support the Covaris S2 sample-prep instrument system, which is based on the company’s Adaptive Focused Acoustic technology.
 
Covaris said this technology uses bead handling and fragment and mate-pair library compilation to speed bead reaction and DNA shearing, enabling generation of up to 35 base pairs of sequence data.
 
Jim Laugharn, President and CEO of Woburn, Mass-based Covaris, said the firm’s instrument “can be used for both high intensity shearing of genomic DNA with one sample and for controlled, gentle mixing of enzymatic reaction beads in the next sample.”

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.